Elranatamab-Bcmm (Anti-BCMA & CD3)
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
2408850-14-4
ElrexfioTM, PF-06863135
C00876-1mg
CD markers
Transmembrane Transporters
Elranatamab-bcmm is a bispecific T-cell engager (BiTE) monoclonal antibody that targets CD3 and B-cell maturation antigen (BCMA), promoting the recruitment and activation of T cells to effectively eliminate malignant myeloma cells. It is FDA-approved for the treatment of adults with relapsed or refractory multiple myeloma. MW: 145.44 KD.
-80°C (avoid freeze-thaw cycles)
Beschrijving
Elranatamab-Bcmm (Anti-BCMA & CD3) Beschikbaar in 1 mg. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten
Anti-TNF-α (Adalimumab), humanized Antibody
A1048-100
100 µg
PEPTIC DIGEST OF ANIMAL TISSUE (MEAT PEPTONE)
P16-102-01
500 g
GelRed® Agarose LE
#41029-5G
1x 5 g
HT115 (DE3) Super Competent Cells
D1045S
10x 100 μL
HT115
ACC-130
10 Tubes
Rat Reticulon-4 receptor, RTN4R ELISA Kit
MBS9325746-01
48 Well
Starfish Genomic DNA
GSF-390
0.025 mg
NPM2
570475-01
50 µg
